Clinical Trials
3 trialsNCT01242930 2016-05-12
Open Label Study With Imetelstat to Determine Effect of Imetelstat in Patients w/ Previously Treated Multiple Myeloma
Geron Corporation
Phase 2 Completed
NCT00594126 2015-12-24
Safety and Dose Study of GRN163L Administered to Treat Patients With Refractory or Relapsed Multiple Myeloma
Geron Corporation
Phase 1 Completed
NCT00718601 2015-12-24
Safety and Dose Study of GRN163L and Velcade to Treat Patients With Refractory or Relapsed Myeloma
Geron Corporation
Phase 1 Completed